Tuesday, 27 February, 2024

02 Jun 2014 | Press Release

news > News and Events > Page 1

Phantom superbugs - a silent killer

Infection Control

University of Queensland researchers have discovered antibiotic-resistant bacteria in the Middle East which is cloaking itself in genetic material to avoid detection and placing the population at increased risk of deadly infections.


With the Middle East an increasingly popular destination for medical tourism and international workers seeking high-paying jobs, researchers warn the hard-to-detect superbugs may quickly spread beyond the region and emerge worldwide.

Researcher Hosam Mamoon Zowawi, from the UQ Centre for Clinical Research, said the 'phantom' superbugs were found during a region-wide collaborative study on superbugs in the Gulf Cooperation Council (GCC) states of Saudi Arabia, United Arab Emirates, Kuwait, Qatar, Oman and Bahrain.

"The study found antibiotic-resistant bacteria in samples from all GCC states," Mr Zowawi said.

"Not only were the bacteria widespread, but they were found to be carrying genetic material which empowers them to resist antibiotics and avoid detection in routine laboratory testing.

"This means patients are not being treated quickly with the right antibiotics, allowing the bacteria time to spread.

"The results of this study will hopefully encourage laboratories to introduce more specific testing techniques to identify and prevent overlooking the presence of phantom superbugs.

"Implementing effective infection control precautions is also essential to minimise the spread of superbugs.

"Several clusters of the phantom superbugs were also detected in different patients from the same hospitals, suggesting patient-to-patient spread of infection is occurring," Mr Zowawi said.

The research team is now developing new diagnostic techniques to rapidly identify antibiotic-resistant bacteria, including the phantom superbug.

"We hope this will help in advancing the surveillance of superbugs by reducing the turnaround time to identify the deadly bacteria," Mr Zowawi said.

"It will also assist clinicians to apply targeted treatment and implement infection control precautions sooner."

The research findings are published in this month's Antimicrobials Agents and Chemotherapy journal.

Related Contacts

Clinical

Techniques

Clinical

Marketing

Stream the latest dental videos...
Expert talk: VITA VIONIC VIGO®

Sponsored Links...

Upcoming Events...

Feb 29 2024
Mar 06 2024
Mar 09 2024
Mar 12 2024
Mar 13 2024
Mar 13 2024
Mar 14 2024

Expodental 2024

Madrid, SPAIN

Mar 15 2024
Mar 16 2024
Mar 21 2024

ADX24 Sydney

Sydney, AUSTRALIA

Mar 22 2024
Apr 05 2024
Apr 12 2024
Apr 16 2024

Dentists Behaving 'Very' Badly

Brisbane, AUSTRALIA

Apr 19 2024
Apr 19 2024

IDEM Singapore 2024

Singapore, SINGAPORE

Apr 23 2024
Apr 24 2024
May 01 2024
May 02 2024
May 09 2024
May 11 2024
May 14 2024
May 22 2024
May 24 2024
May 29 2024
May 30 2024
May 31 2024

Scottish Dental Show 2024

Glasgow, UNITED KINGDOM

May 31 2024

Famdent Show Mumbai 2024

Mumbai, INDIA

Jun 01 2024
Jun 06 2024
Jun 09 2024
Jun 11 2024
Jun 22 2024
Jul 16 2024
Jul 25 2024
Aug 23 2024
Aug 29 2024

Practical Endodontics Workshop

Sydney, AUSTRALIA

Sep 07 2024
Sep 14 2024
Sep 26 2024
Oct 03 2024
Oct 10 2024
Oct 17 2024

ADOHTA 2024 National Congress

Sydney, AUSTRALIA

Oct 24 2024
Nov 13 2024
Nov 29 2024
Mar 25 2025

IDS 2025

Cologne, GERMANY

May 08 2025